Novel Therapies in Managing Patients with Cardiovascular-Kidney-Metabolic Syndrome and Heart Failure
April 04, 2025
AF and VTE: Global Considerations in the Evolving Space of Real-World Data
Renato D. Lopes, MD, MHS, PhD
Valeria Caso, MD, PhD
Alexander T. Cohen, MD, MBBS
Pearls of Wisdom: Optimizing Hyperkalemia Management in Patients with CKD
Matthew R. Weir, MD
Nihar Desai, MD
Ellie Kelepouris, MD, FACP, FAHA
Don't Miss It! Rapid & Accurate AAV Diagnosis
Silke R. Brix, MD, MRCP, SCPR
Andreas Kronbichler, MD
Setting the Stage of Real-World Data vs RCT
Decoding ANCA-Associated Vasculitis (AAV): From Suspicion to Solution
Bernhard Hellmich, MD
Implementing the SOC Induction Therapies in AAV
How Do We Translate Real-World VTE Data Into Everyday Clinical Practice for Ongoing Anticoagulation?
Patient Case Study: Obesity
Implications Associated With Integrating Both Real-World Data and Clinical Trial Data Into Clinical Practice: AF Considerations
Patient Case Study: Obesity and VTE
No Patient Left Behind! Advancing CKD-Associated Pruritus Care
Kieran McCafferty, MD
Maurizio Gallieni, MD
Pulmonary Hypertension: Diagnosis, Management, and Updates – Chairperson’s Perspective
Vallerie V. McLaughlin, MD
Pulmonary Hypertension: Comorbidities With PAH and Group 2 PH
Thomas Cascino, MD
Bradley A. Maron, MD
Pulmonary Hypertension Management: Practice Trends and Updates
Victor Moles, MD
Ioana Preston, MD
The Shifting ATTR-CM Landscape: Early Diagnosis, Emerging Therapies & Personalized Care
Pablo Garcia-Pavia, MD, PhD
Francesco Cappelli, MD
Loading...
We're glad to see you're enjoying PACE-CME… but how about a more personalized experience?
Press cancel to remain on PACE-CME. Press the link below or the continue button to keep going.